PALLA PHARMA LIMITED - Announcements

0.00%

29.5¢

Currently unlisted.

Palla Pharma Limited is an Australia-based vertically integrated pharmaceutical company.... Palla Pharma Limited is an Australia-based vertically integrated pharmaceutical company. The Company's primary activities include production and distribution of Narcotic Raw Material (NRM), Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The Company operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The Company has developed a water-based extraction technology, which is used in NRM production. It operates in Victoria and Tasmania; and northern hemisphere operations based in Norway. It sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.More

FIREBRICK PHARMA

Invest in the Future of Healthcare – Firebrick Pharma’s Investor Webinar

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

PAL	Voluntary Suspension	PRICE SENSITIVE	15/12/21	194.05KB	Share
PAL	Trading Halt	PRICE SENSITIVE	13/12/21	231.5KB	Share
PAL	Response to ASX Price Query	PRICE SENSITIVE	09/12/21	223.11KB	Share
PAL	Sale and Leaseback of Coolaroo Site	PRICE SENSITIVE	26/11/21	736KB	Share
PAL	Investor Update	PRICE SENSITIVE	30/09/21	1.63MB	Share
PAL	Appendix 4D & Preliminary Interim Report - 30 June 2021	PRICE SENSITIVE	31/08/21	284.66KB	Share
PAL	2021 Annual General Meeting Presentation	PRICE SENSITIVE	26/05/21	2.17MB	Share
PAL	Palla Pharma Limited announces new CEO, Mr Giles Moss	PRICE SENSITIVE	26/05/21	362.01KB	Share
PAL	PAL Formal Product Launch & Production Partnership Update	PRICE SENSITIVE	04/05/21	291.51KB	Share
PAL	Palla Pharma successfully completes Retail Entitlement Offer	PRICE SENSITIVE	25/03/21	304.23KB	Share
PAL	First Palla Pharma 30/500 Co-Codamol Caplet Order	PRICE SENSITIVE	19/03/21	82.04KB	Share
PAL	Investor Update	PRICE SENSITIVE	17/03/21	119.85KB	Share
PAL	Retail Entitlement Offer Booklet	PRICE SENSITIVE	09/03/21	3.12MB	Share
PAL	Completion of Placement and Institutional Entitlement Offer	PRICE SENSITIVE	02/03/21	357.19KB	Share
PAL	Entitlement Offer	PRICE SENSITIVE	26/02/21	442.97KB	Share
PAL	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	26/02/21	332.01KB	Share
PAL	FY20 Full Year Results & Capital Raising	PRICE SENSITIVE	26/02/21	2MB	Share
PAL	Trading Halt	PRICE SENSITIVE	26/02/21	362.95KB	Share
PAL	UK Marketing Authorisations Approval Granted	PRICE SENSITIVE	18/02/21	131.18KB	Share
PAL	Market Update - UK MAs, Current Trading and Business Review	PRICE SENSITIVE	01/02/21	113.2KB	Share
PAL	Resignation of Managing Director and Chief Executive Officer	PRICE SENSITIVE	22/12/20	99.68KB	Share
PAL	Marketing Authorisations Approval Process Update	PRICE SENSITIVE	03/12/20	99.11KB	Share
PAL	Investor Update	PRICE SENSITIVE	06/11/20	111.38KB	Share
PAL	Tasmania property sale	PRICE SENSITIVE	23/09/20	96.94KB	Share
PAL	1H20 Results Presentation	PRICE SENSITIVE	31/08/20	1.35MB	Share
PAL	1H20 Results Release Briefing	PRICE SENSITIVE	31/08/20	155.95KB	Share
PAL	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	31/08/20	529.53KB	Share
PAL	FDF contract extension and marketing authorisation update	PRICE SENSITIVE	17/07/20	116.89KB	Share
PAL	2020 Annual General Meeting Presentation	PRICE SENSITIVE	28/05/20	1.46MB	Share
PAL	2020 AGM Chairman's Address	PRICE SENSITIVE	28/05/20	119.22KB	Share
PAL	Palla Pharma UK Acquisition Update	PRICE SENSITIVE	26/05/20	150.2KB	Share
PAL	Palla Pharma UK Acquisition Update	PRICE SENSITIVE	01/04/20	101.6KB	Share
PAL	Palla Pharma Investor Presentation - FY19 Results & Outlook	PRICE SENSITIVE	27/02/20	1.21MB	Share
PAL	Palla Pharma delivers double-digit growth in FY19	PRICE SENSITIVE	27/02/20	147.64KB	Share
PAL	Preliminary Final Report and Annual Report	PRICE SENSITIVE	27/02/20	797.86KB	Share
PAL	Palla Pharma Investor Update	PRICE SENSITIVE	10/02/20	184.4KB	Share
PAL	Palla Pharma renegotiates debt facilities on improved terms	PRICE SENSITIVE	19/12/19	103.96KB	Share
PAL	Palla Pharma exits unprofitable CMO manufacturing agreement	PRICE SENSITIVE	18/12/19	125.3KB	Share
PAL	New CPO Supply Agreement & CPO Production Capacity Expansion	PRICE SENSITIVE	10/12/19	169.39KB	Share
PAL	Palla Pharma Retail Entitlement Offer Booklet	PRICE SENSITIVE	21/10/19	2.1MB	Share
PAL	Palla Pharma completes Placement & Institutional Offer	PRICE SENSITIVE	21/10/19	167.33KB	Share
PAL	PAL Investor Presentation - Placement & Entitlement Offer	PRICE SENSITIVE	17/10/19	1.68MB	Share
PAL	PAL announces Fully Underwritten Capital Raising	PRICE SENSITIVE	17/10/19	110.09KB	Share
PAL	Trading Halt	PRICE SENSITIVE	17/10/19	321.73KB	Share
PAL	Pause in Trading	PRICE SENSITIVE	17/10/19	115.64KB	Share
PAL	Palla 1H2019 Results Investor Presentation	PRICE SENSITIVE	29/08/19	1.24MB	Share
PAL	Palla Announces 1H2019 Financial Results and Trading Update	PRICE SENSITIVE	29/08/19	158.26KB	Share
PAL	Half Yearly Report and Accounts	PRICE SENSITIVE	29/08/19	501.4KB	Share
PAL	New Codeine Phosphate Supply Agreement & 1H2019 Update	PRICE SENSITIVE	23/07/19	99.88KB	Share
PAL	Settlement of High Codeine Poppy Dispute	PRICE SENSITIVE	17/06/19	78.44KB	Share
PAL	TPE 2019 AGM Presentations & Outlook	PRICE SENSITIVE	30/05/19	953.03KB	Share
PAL	S&P DJI Announces March 2019 Quarterly Rebalance	PRICE SENSITIVE	08/03/19	175.31KB	Share
PAL	TPI Enterprises 2018FY Results - Investor Presentation	PRICE SENSITIVE	28/02/19	1.66MB	Share
PAL	Preliminary Final Report	PRICE SENSITIVE	28/02/19	350.99KB	Share
PAL	Patent Litigation Update	PRICE SENSITIVE	25/02/19	112.75KB	Share
PAL	TPI Melbourne Property Acquisition & Debt Facility Extension	PRICE SENSITIVE	30/11/18	111.81KB	Share
PAL	TPE Investor Presentation - 2018 Half Year Results	PRICE SENSITIVE	30/08/18	1.24MB	Share
PAL	Half Yearly Report and Accounts	PRICE SENSITIVE	30/08/18	415.63KB	Share
PAL	TPE signs 3-year Codeine Phosphate Supply Contract	PRICE SENSITIVE	03/08/18	124.76KB	Share
PAL	CEO & Chairman AGM Addresses including Market Update	PRICE SENSITIVE	31/05/18	1.48MB	Share
PAL	TPE Investor Update	PRICE SENSITIVE	30/04/18	102.08KB	Share
PAL	TPE 2017 Results and 2018 Outlook	PRICE SENSITIVE	28/02/18	1.19MB	Share
PAL	TPE 31 December 2017 Appendix 4E and Annual Report	PRICE SENSITIVE	28/02/18	726.76KB	Share
PAL	TPE completes sale of Portugal operations	PRICE SENSITIVE	05/02/18	77.15KB	Share
PAL	TPE signs binding agreement for sale of Portugal operations	PRICE SENSITIVE	06/11/17	366.28KB	Share
PAL	TPE Acquisition and Company Update November 2017	PRICE SENSITIVE	01/11/17	1.52MB	Share
PAL	First batch of Toll processing completed	PRICE SENSITIVE	13/10/17	76.79KB	Share
PAL	TPE announces closing of the Gruveveien Acquisition	PRICE SENSITIVE	03/10/17	81.78KB	Share
PAL	TPE Receives Medicinal Cannabis Licences	PRICE SENSITIVE	29/09/17	361.07KB	Share
PAL	Signs second material European poppy straw supply contract	PRICE SENSITIVE	05/09/17	366.11KB	Share
PAL	Company Update 2017FY Half Year Financial Results	PRICE SENSITIVE	04/09/17	1.85MB	Share
PAL	Half Year Accounts	PRICE SENSITIVE	31/08/17	602.16KB	Share
PAL	TPE ACQUIRES EUROPEAN OPIATE PHARMACEUTICALS BUSINESS	PRICE SENSITIVE	12/07/17	430.37KB	Share
PAL	TPI ENTERPRISES SIGNS 2ND UK CPO SUPPLY AGREEMENT	PRICE SENSITIVE	11/07/17	368.4KB	Share
PAL	TPI ENTERPRISES SIGNS SIGNIFICANT UK CPO SUPPLY AGREEMENT	PRICE SENSITIVE	30/06/17	370.73KB	Share
PAL	CONFIRMS ALL LICENCE APPROVALS FOR TOLL MANUFACTURE	PRICE SENSITIVE	26/05/17	358.83KB	Share
PAL	TPE CONFIRMS NRM TOLL PROCESSING DEAL	PRICE SENSITIVE	03/04/17	236.35KB	Share
PAL	TPI Announces Successful Capital Raising	PRICE SENSITIVE	27/03/17	87.69KB	Share
PAL	Trading Halt	PRICE SENSITIVE	23/03/17	286.83KB	Share
PAL	TPE announces Fully Underwritten Capital Raising of $44.2m	PRICE SENSITIVE	23/03/17	95.45KB	Share
PAL	Trading Halt	PRICE SENSITIVE	21/03/17	215.89KB	Share
PAL	TPE receives two key licence and permit milestones	PRICE SENSITIVE	06/03/17	241.3KB	Share
PAL	Preliminary Final Report	PRICE SENSITIVE	28/02/17	293.33KB	Share
PAL	TPE receives all Hungarian straw import approvals	PRICE SENSITIVE	24/02/17	235.9KB	Share
PAL	TPE Biosecurity Conditions Published for Importation	PRICE SENSITIVE	21/12/16	364.78KB	Share
PAL	TPE AND STERLING TO INCREASE COMPETITION IN UK CPO MARKET	PRICE SENSITIVE	17/11/16	77.15KB	Share
PAL	Half Yearly Report and Accounts-TPE.AX	PRICE SENSITIVE	29/08/16	1.09MB	Share
PAL	TPE secures 5 year supply contract-TPE.AX	PRICE SENSITIVE	02/08/16	237.57KB	Share
PAL	Director Appointment/Resignation-TPE.AX	PRICE SENSITIVE	31/05/16	258.43KB	Share
PAL	TPE market update-TPE.AX	PRICE SENSITIVE	23/05/16	261.23KB	Share
PAL	2015 Preliminary Final Report	PRICE SENSITIVE	01/03/16	1.19MB	Share
PAL	TPE 2015 Preliminary Final Report	PRICE SENSITIVE	26/02/16	1.19MB	Share
PAL	Production and Sales Milestone Update	PRICE SENSITIVE	10/12/15	240.64KB	Share
PAL	Commissioning and Customer Update	PRICE SENSITIVE	11/11/15	233.35KB	Share
PAL	Raw Material Supply Update	PRICE SENSITIVE	21/09/15	247.31KB	Share
PAL	Half Yearly Report and Accounts	PRICE SENSITIVE	28/08/15	816.52KB	Share
PAL	Market Release - admission to the official list	PRICE SENSITIVE	12/08/15	29.73KB	Share

PAL Voluntary Suspension
15/12/21	PRICE SENSITIVE	194.05KB	Share
PAL Trading Halt
13/12/21	PRICE SENSITIVE	231.5KB	Share
PAL Response to ASX Price Query
09/12/21	PRICE SENSITIVE	223.11KB	Share
PAL Sale and Leaseback of Coolaroo Site
26/11/21	PRICE SENSITIVE	736KB	Share
PAL Investor Update
30/09/21	PRICE SENSITIVE	1.63MB	Share
PAL Appendix 4D & Preliminary Interim Report - 30 June 2021
31/08/21	PRICE SENSITIVE	284.66KB	Share
PAL 2021 Annual General Meeting Presentation
26/05/21	PRICE SENSITIVE	2.17MB	Share
PAL Palla Pharma Limited announces new CEO, Mr Giles Moss
26/05/21	PRICE SENSITIVE	362.01KB	Share
PAL PAL Formal Product Launch & Production Partnership Update
04/05/21	PRICE SENSITIVE	291.51KB	Share
PAL Palla Pharma successfully completes Retail Entitlement Offer
25/03/21	PRICE SENSITIVE	304.23KB	Share
PAL First Palla Pharma 30/500 Co-Codamol Caplet Order
19/03/21	PRICE SENSITIVE	82.04KB	Share
PAL Investor Update
17/03/21	PRICE SENSITIVE	119.85KB	Share
PAL Retail Entitlement Offer Booklet
09/03/21	PRICE SENSITIVE	3.12MB	Share
PAL Completion of Placement and Institutional Entitlement Offer
02/03/21	PRICE SENSITIVE	357.19KB	Share
PAL Entitlement Offer
26/02/21	PRICE SENSITIVE	442.97KB	Share
PAL Appendix 4E - Preliminary Final Report
26/02/21	PRICE SENSITIVE	332.01KB	Share
PAL FY20 Full Year Results & Capital Raising
26/02/21	PRICE SENSITIVE	2MB	Share
PAL Trading Halt
26/02/21	PRICE SENSITIVE	362.95KB	Share
PAL UK Marketing Authorisations Approval Granted
18/02/21	PRICE SENSITIVE	131.18KB	Share
PAL Market Update - UK MAs, Current Trading and Business Review
01/02/21	PRICE SENSITIVE	113.2KB	Share
PAL Resignation of Managing Director and Chief Executive Officer
22/12/20	PRICE SENSITIVE	99.68KB	Share
PAL Marketing Authorisations Approval Process Update
03/12/20	PRICE SENSITIVE	99.11KB	Share
PAL Investor Update
06/11/20	PRICE SENSITIVE	111.38KB	Share
PAL Tasmania property sale
23/09/20	PRICE SENSITIVE	96.94KB	Share
PAL 1H20 Results Presentation
31/08/20	PRICE SENSITIVE	1.35MB	Share
PAL 1H20 Results Release Briefing
31/08/20	PRICE SENSITIVE	155.95KB	Share
PAL Appendix 4D and Half Year Financial Report
31/08/20	PRICE SENSITIVE	529.53KB	Share
PAL FDF contract extension and marketing authorisation update
17/07/20	PRICE SENSITIVE	116.89KB	Share
PAL 2020 Annual General Meeting Presentation
28/05/20	PRICE SENSITIVE	1.46MB	Share
PAL 2020 AGM Chairman's Address
28/05/20	PRICE SENSITIVE	119.22KB	Share
PAL Palla Pharma UK Acquisition Update
26/05/20	PRICE SENSITIVE	150.2KB	Share
PAL Palla Pharma UK Acquisition Update
01/04/20	PRICE SENSITIVE	101.6KB	Share
PAL Palla Pharma Investor Presentation - FY19 Results & Outlook
27/02/20	PRICE SENSITIVE	1.21MB	Share
PAL Palla Pharma delivers double-digit growth in FY19
27/02/20	PRICE SENSITIVE	147.64KB	Share
PAL Preliminary Final Report and Annual Report
27/02/20	PRICE SENSITIVE	797.86KB	Share
PAL Palla Pharma Investor Update
10/02/20	PRICE SENSITIVE	184.4KB	Share
PAL Palla Pharma renegotiates debt facilities on improved terms
19/12/19	PRICE SENSITIVE	103.96KB	Share
PAL Palla Pharma exits unprofitable CMO manufacturing agreement
18/12/19	PRICE SENSITIVE	125.3KB	Share
PAL New CPO Supply Agreement & CPO Production Capacity Expansion
10/12/19	PRICE SENSITIVE	169.39KB	Share
PAL Palla Pharma Retail Entitlement Offer Booklet
21/10/19	PRICE SENSITIVE	2.1MB	Share
PAL Palla Pharma completes Placement & Institutional Offer
21/10/19	PRICE SENSITIVE	167.33KB	Share
PAL PAL Investor Presentation - Placement & Entitlement Offer
17/10/19	PRICE SENSITIVE	1.68MB	Share
PAL PAL announces Fully Underwritten Capital Raising
17/10/19	PRICE SENSITIVE	110.09KB	Share
PAL Trading Halt
17/10/19	PRICE SENSITIVE	321.73KB	Share
PAL Pause in Trading
17/10/19	PRICE SENSITIVE	115.64KB	Share
PAL Palla 1H2019 Results Investor Presentation
29/08/19	PRICE SENSITIVE	1.24MB	Share
PAL Palla Announces 1H2019 Financial Results and Trading Update
29/08/19	PRICE SENSITIVE	158.26KB	Share
PAL Half Yearly Report and Accounts
29/08/19	PRICE SENSITIVE	501.4KB	Share
PAL New Codeine Phosphate Supply Agreement & 1H2019 Update
23/07/19	PRICE SENSITIVE	99.88KB	Share
PAL Settlement of High Codeine Poppy Dispute
17/06/19	PRICE SENSITIVE	78.44KB	Share
PAL TPE 2019 AGM Presentations & Outlook
30/05/19	PRICE SENSITIVE	953.03KB	Share
PAL S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19	PRICE SENSITIVE	175.31KB	Share
PAL TPI Enterprises 2018FY Results - Investor Presentation
28/02/19	PRICE SENSITIVE	1.66MB	Share
PAL Preliminary Final Report
28/02/19	PRICE SENSITIVE	350.99KB	Share
PAL Patent Litigation Update
25/02/19	PRICE SENSITIVE	112.75KB	Share
PAL TPI Melbourne Property Acquisition & Debt Facility Extension
30/11/18	PRICE SENSITIVE	111.81KB	Share
PAL TPE Investor Presentation - 2018 Half Year Results
30/08/18	PRICE SENSITIVE	1.24MB	Share
PAL Half Yearly Report and Accounts
30/08/18	PRICE SENSITIVE	415.63KB	Share
PAL TPE signs 3-year Codeine Phosphate Supply Contract
03/08/18	PRICE SENSITIVE	124.76KB	Share
PAL CEO & Chairman AGM Addresses including Market Update
31/05/18	PRICE SENSITIVE	1.48MB	Share
PAL TPE Investor Update
30/04/18	PRICE SENSITIVE	102.08KB	Share
PAL TPE 2017 Results and 2018 Outlook
28/02/18	PRICE SENSITIVE	1.19MB	Share
PAL TPE 31 December 2017 Appendix 4E and Annual Report
28/02/18	PRICE SENSITIVE	726.76KB	Share
PAL TPE completes sale of Portugal operations
05/02/18	PRICE SENSITIVE	77.15KB	Share
PAL TPE signs binding agreement for sale of Portugal operations
06/11/17	PRICE SENSITIVE	366.28KB	Share
PAL TPE Acquisition and Company Update November 2017
01/11/17	PRICE SENSITIVE	1.52MB	Share
PAL First batch of Toll processing completed
13/10/17	PRICE SENSITIVE	76.79KB	Share
PAL TPE announces closing of the Gruveveien Acquisition
03/10/17	PRICE SENSITIVE	81.78KB	Share
PAL TPE Receives Medicinal Cannabis Licences
29/09/17	PRICE SENSITIVE	361.07KB	Share
PAL Signs second material European poppy straw supply contract
05/09/17	PRICE SENSITIVE	366.11KB	Share
PAL Company Update 2017FY Half Year Financial Results
04/09/17	PRICE SENSITIVE	1.85MB	Share
PAL Half Year Accounts
31/08/17	PRICE SENSITIVE	602.16KB	Share
PAL TPE ACQUIRES EUROPEAN OPIATE PHARMACEUTICALS BUSINESS
12/07/17	PRICE SENSITIVE	430.37KB	Share
PAL TPI ENTERPRISES SIGNS 2ND UK CPO SUPPLY AGREEMENT
11/07/17	PRICE SENSITIVE	368.4KB	Share
PAL TPI ENTERPRISES SIGNS SIGNIFICANT UK CPO SUPPLY AGREEMENT
30/06/17	PRICE SENSITIVE	370.73KB	Share
PAL CONFIRMS ALL LICENCE APPROVALS FOR TOLL MANUFACTURE
26/05/17	PRICE SENSITIVE	358.83KB	Share
PAL TPE CONFIRMS NRM TOLL PROCESSING DEAL
03/04/17	PRICE SENSITIVE	236.35KB	Share
PAL TPI Announces Successful Capital Raising
27/03/17	PRICE SENSITIVE	87.69KB	Share
PAL Trading Halt
23/03/17	PRICE SENSITIVE	286.83KB	Share
PAL TPE announces Fully Underwritten Capital Raising of $44.2m
23/03/17	PRICE SENSITIVE	95.45KB	Share
PAL Trading Halt
21/03/17	PRICE SENSITIVE	215.89KB	Share
PAL TPE receives two key licence and permit milestones
06/03/17	PRICE SENSITIVE	241.3KB	Share
PAL Preliminary Final Report
28/02/17	PRICE SENSITIVE	293.33KB	Share
PAL TPE receives all Hungarian straw import approvals
24/02/17	PRICE SENSITIVE	235.9KB	Share
PAL TPE Biosecurity Conditions Published for Importation
21/12/16	PRICE SENSITIVE	364.78KB	Share
PAL TPE AND STERLING TO INCREASE COMPETITION IN UK CPO MARKET
17/11/16	PRICE SENSITIVE	77.15KB	Share
PAL Half Yearly Report and Accounts-TPE.AX
29/08/16	PRICE SENSITIVE	1.09MB	Share
PAL TPE secures 5 year supply contract-TPE.AX
02/08/16	PRICE SENSITIVE	237.57KB	Share
PAL Director Appointment/Resignation-TPE.AX
31/05/16	PRICE SENSITIVE	258.43KB	Share
PAL TPE market update-TPE.AX
23/05/16	PRICE SENSITIVE	261.23KB	Share
PAL 2015 Preliminary Final Report
01/03/16	PRICE SENSITIVE	1.19MB	Share
PAL TPE 2015 Preliminary Final Report
26/02/16	PRICE SENSITIVE	1.19MB	Share
PAL Production and Sales Milestone Update
10/12/15	PRICE SENSITIVE	240.64KB	Share
PAL Commissioning and Customer Update
11/11/15	PRICE SENSITIVE	233.35KB	Share
PAL Raw Material Supply Update
21/09/15	PRICE SENSITIVE	247.31KB	Share
PAL Half Yearly Report and Accounts
28/08/15	PRICE SENSITIVE	816.52KB	Share
PAL Market Release - admission to the official list
12/08/15	PRICE SENSITIVE	29.73KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

PALLA PHARMA LIMITED - Announcements

Announcements

Top Stories